These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9741994)

  • 1. Tetrofosmin thyroid scintigraphy.
    Klain M; Cuocolo A; Salvatore M; Maurea S
    Eur J Nucl Med; 1998 Jul; 25(7):816. PubMed ID: 9741994
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences between 99mTc-sestamibi and 99mTc-tetrofosmin uptake in thyroid and salivary glands: comparison with 99mTc-pertechnetate in 86 subjects.
    Giordano A; Meduri G; Marozzi P; Rubini G; Burroni L; Cappagli M
    Nucl Med Commun; 2003 Mar; 24(3):321-6. PubMed ID: 12612474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium-99m-tetrofosmin scintigraphy, P-glycoprotein and lung cancer.
    Tabuenca MJ; Vargas JA; Varela A; Salas C; Durántez A; Ortiz Berrocal J
    J Nucl Med; 1998 Oct; 39(10):1830-1. PubMed ID: 9776299
    [No Abstract]   [Full Text] [Related]  

  • 4. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
    Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
    J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy and uptake of technetium-99m sestamibi in breast cancer: reply.
    Fukushima K; Ishii K; Sakai E
    Eur J Nucl Med; 1998 Jul; 25(7):816-8. PubMed ID: 9741995
    [No Abstract]   [Full Text] [Related]  

  • 6. [Various dynamics of Tc-99m-tetrofosmin and Tc-99m-MIBI in a parathyroid adenoma].
    Nowak B; Sabri O; Hoff C; Reinartz P; Kleinhans E; Zimny M
    Nuklearmedizin; 1999; 38(5):160-3. PubMed ID: 10488484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy and uptake of technetium-99m sestamibi in breast cancer.
    Derebek E
    Eur J Nucl Med; 1998 Apr; 25(4):448. PubMed ID: 9643975
    [No Abstract]   [Full Text] [Related]  

  • 8. [The use of imaging modalities in patient with thyroid nodule: ultrasonography and radionuclide scintigraphy with new tracers].
    Hod N; Strauss S; Horne T
    Harefuah; 2001 May; 140(5):421-4. PubMed ID: 11419067
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduction of 99mTc-sestamibi and 99mTc-tetrofosmin uptake in MRP-expressing breast cancer cells under hypoxic conditions is independent of MRP function.
    Kinuya S; Li XF; Yokoyama K; Mori H; Shiba K; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1529-31. PubMed ID: 14579093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging multidrug resistance with radiolabeled substrates for P-glycoprotein and multidrug resistance protein.
    Ballinger JR
    Cancer Biother Radiopharm; 2001 Feb; 16(1):1-7. PubMed ID: 11279792
    [No Abstract]   [Full Text] [Related]  

  • 11. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
    Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
    J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of 99Tcm-tetrofosmin lung uptake: a modified method to avoid the contribution from high chest wall activity.
    Heiba SI; Ziada G; Higazy E; Saleh M; Elgazzar AH
    Nucl Med Commun; 1998 Sep; 19(9):859-66. PubMed ID: 10581592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular breast imaging with gamma emitters.
    Schillaci O; Spanu A; Danieli R; Madeddu G
    Q J Nucl Med Mol Imaging; 2013 Dec; 57(4):340-51. PubMed ID: 24322791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordant washout of 99mTc sestamibi and 99mTc tetrofosmin in a patient with mediastinal seminoma.
    Ishibashi M; Fujimoto K; Ohzono H; Fujii T; Koganemaru M; Hayabuchi N
    Acta Oncol; 1998; 37(2):203-4. PubMed ID: 9636017
    [No Abstract]   [Full Text] [Related]  

  • 16. Monitoring therapy in breast cancer.
    Buscombe JR
    Nucl Med Commun; 2002 Jul; 23(7):619-24. PubMed ID: 12089483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast scintigraphy].
    Prats E; Razola P; García López F; Dolores Abós M; Banzo J
    Rev Esp Med Nucl; 2001 Feb; 20(1):47-70. PubMed ID: 11181333
    [No Abstract]   [Full Text] [Related]  

  • 18. Technetium-99m-tetrofosmin uptake in sarcoidosis stage I.
    Tschabitscher D; Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Molnar M; Dinges HP; Kroiss A; Lind P
    J Nucl Med; 1997 Nov; 38(11):1786-7. PubMed ID: 9374356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
    Apostolopoulos DJ; Houstoulaki E; Giannakenas C; Alexandrides T; Spiliotis J; Nikiforidis G; Vlachojannis JG; Vassilakos PJ
    J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The breast cancer cell line MCF7 as a model of 99mTc-SestaMIBI, 99mTc-tetrofosmin and 99mTc-Medronate incorporation.
    Molteni SN; Seregni E; Botti C; Martinetti A; Ferrari L; Crippa F; Bombardieri E
    Anticancer Res; 1999; 19(1A):255-9. PubMed ID: 10226551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.